1.025
price down icon0.49%   -0.005
after-market Handel nachbörslich: 1.03 0.005 +0.49%
loading
Schlusskurs vom Vortag:
$1.03
Offen:
$1.03
24-Stunden-Volumen:
17,911
Relative Volume:
0.13
Marktkapitalisierung:
$5.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-3.12M
KGV:
-0.2129
EPS:
-4.8149
Netto-Cashflow:
$-2.69M
1W Leistung:
+8.80%
1M Leistung:
+15.17%
6M Leistung:
-54.04%
1J Leistung:
-36.34%
1-Tages-Spanne:
Value
$1.00
$1.0484
1-Wochen-Bereich:
Value
$0.98
$1.14
52-Wochen-Spanne:
Value
$0.6578
$17.75

180 Life Sciences Corp Stock (ATNF) Company Profile

Name
Firmenname
180 Life Sciences Corp
Name
Telefon
650-507-0669
Name
Adresse
3000 EL CAMINO REAL, PALO ALTO
Name
Mitarbeiter
2
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ATNF's Discussions on Twitter

Vergleichen Sie ATNF mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATNF
180 Life Sciences Corp
1.025 5.37M 0 -3.12M -2.69M -4.8149
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-09-15 Eingeleitet Maxim Group Buy

180 Life Sciences Corp Aktie (ATNF) Neueste Nachrichten

pulisher
May 27, 2025

4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World

May 27, 2025
pulisher
May 27, 2025

Best Toy Stocks To Watch Now – May 25th - Defense World

May 27, 2025
pulisher
May 23, 2025

Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga

May 23, 2025
pulisher
May 22, 2025

Layoff Tracker: Eikon Cuts Workforce by 15%, Citing ‘External Forces’ - BioSpace

May 22, 2025
pulisher
May 11, 2025

180 Life Sciences’ (ATNF) Sell (E+) Rating Reiterated at Weiss Ratings - Defense World

May 11, 2025
pulisher
May 02, 2025

180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program - Barchart.com

May 02, 2025
pulisher
May 02, 2025

ATNF’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

May 02, 2025
pulisher
May 01, 2025

180 Life Sciences Gets Notice of Allowance for Method to Prevent POCD - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

MAGIC Nashville Showcases Premier Southeastern Women's Fashion Trends and Innovations - Digital Journal

May 01, 2025
pulisher
May 01, 2025

180 Life Sciences (ATNF) Secures Patent Approval for POCD Treatm - GuruFocus

May 01, 2025
pulisher
May 01, 2025

180 Life Sciences nears patent for post-surgery cognitive aid By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

180 Life Sciences nears patent for post-surgery cognitive aid - Investing.com

May 01, 2025
pulisher
May 01, 2025

180 Life Sciences Corp. Announces Notice of Allowance for U.S. P - GuruFocus

May 01, 2025
pulisher
May 01, 2025

180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction | ATNF Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
May 01, 2025

Patent Breakthrough: 180 Life Sciences Develops First Treatment to Prevent Post-Surgery Cognitive Decline in Elderly - Stock Titan

May 01, 2025
pulisher
Apr 30, 2025

Budapest Draws in Summer Visitors for an Adventure Along the Danube - Digital Journal

Apr 30, 2025
pulisher
Apr 30, 2025

180 Life Sciences (ATNF) Restructures Capital with Share Repurch - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

180 Life Sciences to buy back shares, simplifies capital structure By Investing.com - Investing.com India

Apr 30, 2025
pulisher
Apr 30, 2025

180 Life Sciences Settles Disputes with Elray Resources - TipRanks

Apr 30, 2025
pulisher
Apr 30, 2025

180 Life Sciences Corp. Announces Share Repurchase | ATNF Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

180 Life Sciences to buy back shares, simplifies capital structure - Investing.com Australia

Apr 30, 2025
pulisher
Apr 30, 2025

180 Life Sciences Launches Massive 23% Share Reduction Plan: Key Details of $1M Strategic Buyback - Stock Titan

Apr 30, 2025
pulisher
Apr 30, 2025

180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Increase in Short Interest - Defense World

Apr 30, 2025
pulisher
Apr 30, 2025

Short Interest in Adlai Nortye Ltd. (NASDAQ:ANL) Decreases By 51.6% - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Q4 Results This Week: BPCL, Varun Beverages, Vedanta, SBI, Trent Among 180+ Companies To Declare Earnings - NDTV Profit

Apr 29, 2025
pulisher
Apr 27, 2025

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 26, 2025

180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 25, 2025

180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World

Apr 25, 2025
pulisher
Apr 25, 2025

Dupuytren's Disease Market Valuation Expected To Reach $8.54 Billion By 2029 Growing At A Rate Of 9% As Rev... - WhaTech

Apr 25, 2025
pulisher
Apr 19, 2025

Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

Apr 17, 2025
pulisher
Apr 17, 2025

Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings - Yahoo Finance

Apr 17, 2025
pulisher
Apr 14, 2025

Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

Apr 14, 2025
pulisher
Apr 11, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Best Penny Stocks for Today (Charts Updated Daily) - Benzinga

Apr 11, 2025
pulisher
Apr 09, 2025

Elray Resources Announces Strategic Sale of Crypto iGaming Technology - ADVFN

Apr 09, 2025
pulisher
Apr 09, 2025

Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews

Apr 09, 2025
pulisher
Apr 09, 2025

Weiss Ratings Reiterates Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World

Apr 09, 2025
pulisher
Apr 09, 2025

180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - The AM Reporter

Apr 09, 2025
pulisher
Apr 08, 2025

ATNF stock touches 52-week low at $0.74 amid market shifts - Investing.com India

Apr 08, 2025
pulisher
Apr 08, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 08, 2025
pulisher
Apr 05, 2025

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire

Apr 05, 2025
pulisher
Apr 02, 2025

Siemens acquires Dotmatics to extend AI-powered software portfolio to Life Sciences - Siemens press

Apr 02, 2025
pulisher
Mar 31, 2025

180 Life Sciences Corp. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

ATNF stock touches 52-week low at $0.98 amid market shifts - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

180 Life Sciences Corp. (ATNF) reports earnings - qz.com

Mar 31, 2025
pulisher
Mar 30, 2025

Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Increases By 67.2% - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

180 Life Sciences (NASDAQ:ATNF) versus Immunic (NASDAQ:IMUX) Head to Head Comparison - Defense World

Mar 28, 2025
pulisher
Mar 24, 2025

Motor Neuron Disease Clinical Pipeline | 180+ Companies Advancing Next-Generation Therapies - openPR

Mar 24, 2025

Finanzdaten der 180 Life Sciences Corp-Aktie (ATNF)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):